Cécile van Steen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Combination Therapy

Myasthenia Gravis

Optical Coherence Tomography

Ejection Fraction

Top Venues

Advances in therapy

Clinical ophthalmology (Auckland, N.Z.)

Journal of ophthalmology

This page only lists publications with an associated author ORCID identifier.

Publications

Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy 41 (6) (2024)
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy (2024)
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy 41 (6) (2024)
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy 41 (6) (2024)
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy 41 (6) (2024)
Carlo Lazzaro, Cécile van Steen, Florent Aptel, Cédric Schweitzer, Luigi Angelillo
Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France. Journal of ophthalmology 2022 (2022)
Carlo Lazzaro, Cécile van Steen, Stephan Billeit, Heinrich Frauenknecht, Christopher Kallen, Stefan Pfennigsdorf, Ulrich Thelen, Luigi Angelillo
Cost-Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany. Clinical ophthalmology (Auckland, N.Z.) 16 (2022)
Nancy E Cross, Cécile van Steen, Yasmina Zegaoui, Andrew Satherley, Luigi Angelillo
Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs. Clinical ophthalmology (Auckland, N.Z.) 16 (2022)
Nancy E Cross, Cécile van Steen, Yasmina Zegaoui, Andrew Satherley, Luigi Angelillo
Current and Future Treatment of Retinitis Pigmentosa. Clinical ophthalmology (Auckland, N.Z.) 16 (2022)